Browsing Helseledelse og helseøkonomi by Title
Now showing items 41-60 of 383
-
(Master thesis / Masteroppgave, 2018)
-
(Master thesis / Masteroppgave, 2018)BACKGROUND: Differences in the pace of implementation and degree of diffusion of Electronic Patient Record (EPR) systems can be observed between Germany and Norway. Whereas EPR systems are implemented nationwide in Norway, ...
-
(Master thesis / Masteroppgave, 2014)Background: CAM has gained increased popularity in Western countries in recent years. Its use is commonly associated with chronic diseases management and disease prevention. While CAM utilization is becoming more usual, ...
-
(Master thesis / Masteroppgave, 2015)Coordination of patients between specialist- and primary care - An explorative study of hospitals´ invoicing practices in the wake of introduction of municipal co-financing Background. As a response to overarching ...
-
(Master thesis / Masteroppgave, 2010)BACKGROUND: In June 2009, the Norwegian government presented a proposal for one of the most central health reforms in Norway during the last decades, white paper (St.melding) no. 47, The Coordination Reform. The intention ...
-
(Master thesis / Masteroppgave, 2012)Background and purpose Little research has been done on the differences in resource consumption within patient groups based on other factors than number of hospital days. Up until now most hospitals have worked with a ...
-
(Master thesis / Masteroppgave, 2015)Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia and is present in around 1-2 % of the European population. In Norway the estimated prevalence is 65-82 000, and it is expected to double by 2060. ...
-
(Master thesis / Masteroppgave, 2011)Background: The Nordic countries’ welfare state is under increased pressure. Health care expenditures are rising and expected to do so in the coming decades. It is therefore interesting to find out if the Norwegian specialist ...
-
(Master thesis / Masteroppgave, 2016)Background: Antibiotic resistance is an increasingly important issue, with many authors and public health organizations emphasizing the urgent need for action. Antibiotic resistance is a negative externality and relevant ...
-
(Master thesis / Masteroppgave, 2014)Rheumatoid arthritis is an inflammatory disease that affect 0.5% - 1.0% of the population world-wide and approximately 0.5% in Norway. RA places a considerable burden on patients in terms morbidity and mortality, and on ...
-
Cost-Effectiveness Analyses of General Tar-geted Therapy in Non-Small Cell Lung Can-cer: a Systematic ReviewRestricted Access (Master thesis / Masteroppgave, 2014)The thesis performs a systematic review of cost-effectiveness (CE) evaluation studies on targeted therapy procedures for non-small cell lung cancer (NSCLC). It identifies the work done in this field, establishes the relative ...
-
(Master thesis / Masteroppgave, 2023)
-
(Master thesis / Masteroppgave, 2017)Background- Uganda is one of the countries with a high economic burden of both cervical cancer and HIV/AIDS. These two diseases share the same risk factors and women with HIV/AIDS have two to twelve chances of suffering ...
-
(Master thesis / Masteroppgave, 2017)
-
(Master thesis / Masteroppgave, 2016)Title: Cost-Effectiveness Analysis of PCSK9 Inhibitors in Norway Introduction & Background: Cardiovascular disease (CVD) is the biggest cause of premature death and loss of quality of life in the developed world. Despite ...
-
(Master thesis / Masteroppgave, 2014)
-
(Master thesis / Masteroppgave, 2013)Traumatic brain injury (TBI) is a craniocerebral trauma which causes long-term physical, cognitive and emotional impairment and adds substantially to the healthcare burden. The cost of TBIs is believed to be huge in Norway. ...
-
Cost-effectiveness of first-line detection strategies for obstructive sleep apnea syndrome in adults compared to common practice in the NetherlandsRestricted Access (Master thesis / Masteroppgave, 2015)
-
(Master thesis / Masteroppgave, 2010)[Background] Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that does not react to certain antibiotics and has become the major cause of nosocomial infections. Both the treatments and precautions ...